Bengur Bryan Advises CoreMedica Laboratories, Inc.

Bengur Bryan privately placed Series A Preferred Stock for CoreMedica in support of its future growth.

CoreMedica Laboratories Inc. is a Kansas City-based provider of cost effective laboratory blood testing for the early detection of common diseases, management of ongoing medical treatment and other wellness screening purposes.  The Company’s innovative methodology uses micro sample collection of capillary blood to provide a less expensive and more reliable alternative system to traditional venous blood collection and testing. CoreMedica’s customers include leading wellness screening providers, major retailers providing wellness screening kits and services, pharmaceutical companies and major medical research organizations and universities.